Longduoduo Co

Longduoduo Co Financial Leverage

The Financial Leverage (Equity Multiplier) of Longduoduo Co (LDDD) as of Nov 3, 2026 is 2.93. In the previous year, Financial Leverage (Equity Multiplier) was 1.80 — a change of 63.35% (higher).

Financial Leverage

2.93

YoY

63.35%

Last updated:

Financial Leverage (Equity Multiplier) of Longduoduo Co is 2026 2.93 . Financial Leverage (Equity Multiplier) of Longduoduo Co was 2025 1.80 . It decreases by 63.35% higher compared to the previous year.

The Longduoduo Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2020
1.00 USD
Jan 1, 2021
-1.54 USD
Jan 1, 2022
-0.66 USD
Jan 1, 2023
-2.74 USD
Jan 1, 2024
2.94 USD
Jan 1, 2025
1.80 USD
Jan 1, 2026
2.93 USD
The Longduoduo Co Financial Leverage history
YEARFinancial LeverageYoY
2.93+63.35%
1.80-38.88%
2.94-207.35%
-2.74+316.12%
-0.66-57.23%
-1.54-253.74%
1.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Longduoduo Co Stock analysis

What does Longduoduo Co do? Longduoduo Co Ltd operates in the Health Care Providers & Services industry, focusing on preventive care for cardiovascular and cerebrovascular diseases such as myocardial infarction and cerebral infarction. The company collaborates with third-party healthcare service providers to offer preventive healthcare solutions, including health products and medical examinations. Its primary market is domestic, serving customers seeking preventive services for conditions like hemiplegia and cardiovascular diseases. The firm's revenue comes from providing these integrated preventive care services through its partnerships and domestic operations. Longduoduo Co Ltd generates income by delivering preventive healthcare solutions that combine health products with medical examinations and services. The company partners with third-party healthcare service providers to expand its service offerings, targeting individuals concerned about cardiovascular and cerebrovascular health risks. Domestic customers purchase these preventive care packages, which address specific health issues including myocardial infarction prevention and hemiplegia management. The business model relies on domestic market sales of these integrated health solutions. The company's revenue streams are derived from domestic sales of preventive healthcare services, including health products and medical examinations provided through third-party partnerships. Longduoduo focuses on cardiovascular and cerebrovascular disease prevention, targeting customers interested in avoiding conditions like myocardial infarction and cerebral infarction. Its services are designed to address specific health concerns such as hemiplegia, with the firm operating exclusively within the domestic market to deliver these preventive care solutions. Longduoduo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Longduoduo Co stock

Financial Leverage (Equity Multiplier) of Longduoduo Co is 2.93 in 2026.

Financial Leverage (Equity Multiplier) of Longduoduo Co changed from 1.80 to 2.93, representing a 63.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Longduoduo Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Longduoduo Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Longduoduo Co

All Key Metrics — Longduoduo Co